Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 71Breast Neoplasms 45Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 21Neoplasm Metastasis 14Adenocarcinoma 13Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Colorectal Neoplasms 8Melanoma 7Carcinoma 7Head and Neck Neoplasms 6Digestive System Neoplasms 6Cholangiocarcinoma 6Small Cell Lung Carcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Pancreatic Diseases 5Pancreatic Adenocarcinoma 5Ovarian Neoplasms 5Digestive System Diseases 5Carcinoma, Pancreatic Ductal 5Stomach Neoplasms 4Sarcoma 4Recurrence 4Neoplasms by Site 4Gallbladder Neoplasms 4Fallopian Tube Neoplasms 4Endocrine Gland Neoplasms 4Carcinoma, Squamous Cell 4

Interventions

Pemetrexed 23Cisplatin 19Nivolumab 8Gemcitabine 7Ipilimumab 6Carboplatin 6pembrolizumab 4Bevacizumab 4tazemetostat 3durvalumab 3Fluorouracil 3Drug Therapy 3spartalizumab 2olaparib 2niraparib 2budigalimab 2belinostat 2anetumab ravtansine 2amatuximab 2Vinorelbine 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2PM 01183 2Oxaliplatin 2Imatinib Mesylate 2Everolimus 2Erlotinib Hydrochloride 2Doxorubicin 2Cyclophosphamide 2venetoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Mesothelioma × 130-nm albumin-bound paclitaxel × Clear all
NCT02798536 2022-08-23

Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
21 enrolled 19 charts
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡